/

What is the Grey Market Premium (GMP) and should I rely on it?

The Grey Market Premium (GMP) is the unofficial premium at which IPO shares trade in an informal, unregulated market before the stock actually lists, expressed as the extra amount buyers are willing to pay over the issue price. You shouldn't rely on it as your main decision-making tool, it's not regulated or verified by SEBI, NSE, or BSE, and its accuracy varies significantly depending on the IPO.

How GMP works

If an IPO is priced at ₹500 and the GMP is ₹100, the grey market is signalling an expected listing price of around ₹600. A negative GMP suggests the grey market expects the stock to list below its issue price, generally considered a more reliable warning sign than a high positive GMP, which can sometimes overstate expectations, especially during bullish market phases.

Why it's risky to rely on

The grey market operates entirely outside SEBI's regulatory framework, informally, often through personal networks, with no central clearing, no legal enforceability, and no official verification. SEBI has specifically cautioned investors against grey market participation. On top of that, reliability isn't consistent:

  • GMP tends to be a reasonably useful directional signal for large, heavily subscribed mainboard IPOs with strong institutional participation.
  • For SME IPOs, GMP is considerably less reliable, since thin trading volumes mean a small number of dealers can move the quoted price with limited real demand behind it.
  • Even for mainboard IPOs, GMP is a poor predictor of the exact listing price, at best, it's a rough signal of direction, not a number to bank on.

A better approach

Treat GMP as one input among several, not a standalone signal. It's worth weighing alongside the IPO's actual subscription data (especially QIB participation), the company's fundamentals, and its offer document, rather than making a decision based on GMP figures circulating on social media or unofficial IPO tracking sites.